| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Henneman John B III serves as a Director at OFIX and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 5 buys and 0 sells.
Historically, Henneman John B III's trades have earned a below-average insider score of 24/100 across 3 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -52.9%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | OFIX Orthofix Medical Inc. | Director | Buy | 5,000 | $12.26 | $61,295.00 | +5.8% | - | - | |
| May 1, 2026 | ANIK Anika Therapeutics, Inc. | Director | Buy | 5,000 | $14.66 | $73,319.50 | +10.0% | +21.7% | - | |
| Mar 13, 2024 | APRE Aprea Therapeutics, Inc. | Director | Buy | 6,860 | $7.29 | $50,009.40 | +536.4% | -19.6% | -57.2% | |
| May 18, 2021 | ANIK Anika Therapeutics, Inc. | Director | Buy | 2,000 | $42.86 | $85,720.00 | +21.5% | -0.6% | -48.6% | |
| Oct 7, 2019 | APRE Aprea Therapeutics, Inc. | Director | Buy | 5,000 | $15.00 | $75,000.00 | New | - | - |